The prescribing pattern of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in patient with type two diabetes mellitus: A two-center retrospective cross-sectional study

• Үндсэн зохиолчид: Ghazwa B. Korayem (Зохиогч), Omar A. Alshaya (Зохиогч), Albandari A. Alghamdi (Зохиогч), Shahad S. Alanazi (Зохиогч), Renad T. Almutib (Зохиогч), Mahdi Alsaileek (Зохиогч), Abdulrahman Alrashidi (Зохиогч), Nasser Aldosari (Зохиогч), Nader Bin Sheraim (Зохиогч), Majed S. Al Yami (Зохиогч), Omar A. Almohammed (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

BackgroundThe use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) in patients with type 2 diabetes mellitus (T2DM) remains limited, especially in those with other compelling indications. Thus, this study aimed to describe the prescribing...